BOSTON -- Inhaled corticosteroids (ICS) combined either with formoterol (Foradil) or short-acting beta-agonists (SABA) for asthma treatment were associated with reduced risks of severe ...
Formoterol Fumarate: Following inhaled administration ... Inform patients that long-term use of ICS may increase the risk of some eye problems (cataracts or glaucoma); consider regular eye ...
Current controller drugs for asthma include ICS, LABA, LTRA ... Current benefits from inhaled LABA such as salmeterol and formoterol in the treatment of asthma continue to outweigh risks, which ...
COPD: Chronic obstructive pulmonary disease; EIB: Exercise-induced bronchoconstriction; IβA: Inhaled β 2-agonist; ICS: Inhaled corticosteroid. Globally, the prevalence of asthma continues to ...
Seretide/Advair (fluticasone propionate + salmeterol; GlaxoSmithKline) and Symbicort (budesonide + formoterol fumarate dihydrate; AstraZeneca), which are ICS–LABA combinations, are other popular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results